Viking Therapeutics Statistics
Total Valuation
VKTX has a market cap or net worth of $6.14 billion. The enterprise value is $5.21 billion.
Important Dates
The last earnings date was Wednesday, October 23, 2024, after market close.
| Earnings Date | Oct 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VKTX has 111.44 million shares outstanding. The number of shares has increased by 19.97% in one year.
| Current Share Class | 111.44M |
| Shares Outstanding | 111.44M |
| Shares Change (YoY) | +19.97% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 2.08% |
| Owned by Institutions (%) | 74.30% |
| Float | 105.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.73 |
| P/TBV Ratio | 6.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 36.47, with a Debt / Equity ratio of 0.00.
| Current Ratio | 36.47 |
| Quick Ratio | 36.23 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,395.50 |
Financial Efficiency
Return on equity (ROE) is -15.50% and return on invested capital (ROIC) is -13.06%.
| Return on Equity (ROE) | -15.50% |
| Return on Assets (ROA) | -12.68% |
| Return on Capital (ROIC) | -13.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.67M |
| Employee Count | 27 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +462.99% in the last 52 weeks. The beta is 0.99, so VKTX's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +462.99% |
| 50-Day Moving Average | 64.73 |
| 200-Day Moving Average | 61.47 |
| Relative Strength Index (RSI) | 35.87 |
| Average Volume (20 Days) | 6,402,846 |
Short Selling Information
The latest short interest is 13.28 million, so 11.92% of the outstanding shares have been sold short.
| Short Interest | 13.28M |
| Short Previous Month | 14.39M |
| Short % of Shares Out | 11.92% |
| Short % of Float | 12.59% |
| Short Ratio (days to cover) | 3.89 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -133.97M |
| Pretax Income | -96.75M |
| Net Income | -99.15M |
| EBITDA | n/a |
| EBIT | -133.97M |
| Earnings Per Share (EPS) | -$0.93 |
Full Income StatementBalance Sheet
The company has $930.44 million in cash and $1.24 million in debt, giving a net cash position of $929.21 million or $8.34 per share.
| Cash & Cash Equivalents | 930.44M |
| Total Debt | 1.24M |
| Net Cash | 929.21M |
| Net Cash Per Share | $8.34 |
| Equity (Book Value) | 911.45M |
| Book Value Per Share | 8.18 |
| Working Capital | 910.96M |
Full Balance SheetCash Flow
| Operating Cash Flow | -74.25M |
| Capital Expenditures | n/a |
| Free Cash Flow | -74.25M |
| FCF Per Share | -$0.67 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |